Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Baudaxbio, Eyepoint, Imvax, Ionis, Janssen, Neuraly, Novartis, Novo Nordisk, Nrx, Ocugen, Olix, TME, Unity, Yishengbio.

Biopharmas raising money in public or private financings, including: Albert Labs, Argenx, Cora, Harpoon, Milestone, Oncoverity, TC Biopharm and Umecrine Cognition.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Femdx Medsystems, Getinge.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Equipped MD, G Medical Innovations, Hemex Health, Medinbox, Micare Path, Spectral MD.

Med-tech firms raising money in public or private financings, including: Delcath, Invo Bioscience.

New hires and promotions in the med-tech industry, including: Opsens.

The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boehringer Ingelheim, Henlius, Incyte, Janssen, PTC.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biochestra, Codiak, Crispr, Everest, Firefly Neuro, Gilead, Immunomedics, Merck, Pfizer, Stalicla, Vertex.